A wide variety of mechanisms have been implicated in biglycan-mediated tumor progression, including upregulation of VEGF [27,28], the binding of biglycan to toll-like receptors [29], or by modulation of signaling pathways including the canonical Wnt pathway [20] and the NF-κB pathway [26]. This evidence concerns the gene NFKB1 and neoplasm.